The FDA is one step closer to approving a cure for sickle cell disease that uses CRISPR gene editing. It would be the first approve drug to use gene editing.
FDA moves closer to sickle cell cure that uses gene editing nbcnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nbcnews.com Daily Mail and Mail on Sunday newspapers.
Immix Biopharma (IMMX) Appoints Michaela Liedtke to its Scientific Advisory Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Dr. Liedtke joins Nexcella Scientific Advisory Board with decades of hematology/oncology clinical trial experience at Stanford University Medical CenterDr. Liedtke is a recognized thought leader in.